Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Botulinum toxin A considered good value for money

    This is a preview of subscription content, log in to check access.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Botulinum toxin A considered good value for money. Pharmacoecon. Outcomes News 603, 6 (2010). https://doi.org/10.2165/00151234-201006030-00013

    Download citation

    Keywords

    • Multiple Sclerosis
    • Urinary Incontinence
    • Outcome News
    • Multiple Sclerosis Patient
    • Botulinum Toxin